Literature DB >> 22972559

The receptor-dependent LQTA-QSAR: application to a set of trypanothione reductase inhibitors.

Euzébio G Barbosa1, Kerly Fernanda M Pasqualoto, Márcia M C Ferreira.   

Abstract

A new Receptor-Dependent LQTA-QSAR approach, RD-LQTA-QSAR, is proposed as a new 4D-QSAR method. It is an evolution of receptor independent LQTA-QSAR. This approach uses the free GROMACS package to carry out molecular dynamics simulations and generates a conformational ensemble profile for each compound. Such an ensemble is used to build molecular interaction field-based QSAR models, as in CoMFA. To show the potential of this methodology, a set of 38 phenothiazine derivatives that are specific competitive T. cruzi trypanothione reductase inhibitors, was chosen. Using a combination of molecular docking and molecular dynamics simulations, the binding mode of the phenotiazine derivatives was evaluated in a simulated induced fit approach. The ligands alignments were performed using both ligand and binding site atoms, enabling unbiased alignment. The models obtained were extensively validated by leave-N-out cross-validation and y-randomization techniques to test for their robustness and absence of chance correlation. The final model presented Q(2) LOO of 0.87 and R² of 0.92 and a suitable external prediction of [Formula: see text]= 0.78. The adapted binding site obtained is useful to perform virtual screening and ligand structure-based design and the descriptors in the final model can aid in the design new inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972559     DOI: 10.1007/s10822-012-9598-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.

Authors:  T J Benson; J H McKie; J Garforth; A Borges; A H Fairlamb; K T Douglas
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  LQTA-QSAR: a new 4D-QSAR methodology.

Authors:  João Paulo A Martins; Euzébio G Barbosa; Kerly F M Pasqualoto; Márcia M C Ferreira
Journal:  J Chem Inf Model       Date:  2009-06       Impact factor: 4.956

5.  A virtual screening approach applied to the search for trypanothione reductase inhibitors.

Authors:  D Horvath
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

6.  Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors.

Authors:  C H Faerman; S N Savvides; C Strickland; M A Breidenbach; J A Ponasik; B Ganem; D Ripoll; R L Krauth-Siegel; P A Karplus
Journal:  Bioorg Med Chem       Date:  1996-08       Impact factor: 3.641

7.  The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution.

Authors:  Y Zhang; C S Bond; S Bailey; M L Cunningham; A H Fairlamb; W N Hunter
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

8.  Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.

Authors:  C S Bond; Y Zhang; M Berriman; M L Cunningham; A H Fairlamb; W N Hunter
Journal:  Structure       Date:  1999-01-15       Impact factor: 5.006

9.  Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.

Authors:  Seheli Parveen; Mohammed O F Khan; Susan E Austin; Simon L Croft; Vanessa Yardley; Peter Rock; Kenneth T Douglas
Journal:  J Med Chem       Date:  2005-12-15       Impact factor: 7.446

10.  Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.

Authors:  M O Khan; S E Austin; C Chan; H Yin; D Marks; S N Vaghjiani; H Kendrick; V Yardley; S L Croft; K T Douglas
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

View more
  3 in total

1.  Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model.

Authors:  Ashish M Kanhed; Radha Charan Dash; Nishant Parmar; Tarun Kumar Das; Rajani Giridhar; Mange Ram Yadav
Journal:  Mol Divers       Date:  2015-07-17       Impact factor: 2.943

2.  Molecular dynamics-guided receptor-dependent 4D-QSAR studies of HDACs inhibitors.

Authors:  Zhihao Hu; Qianxia Lin; Haiyun Liu; Tiansheng Zhao; Bowen Yang; Guogang Tu
Journal:  Mol Divers       Date:  2021-02-24       Impact factor: 2.943

Review 3.  Two Decades of 4D-QSAR: A Dying Art or Staging a Comeback?

Authors:  Andrzej Bak
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.